Literature DB >> 28514502

Structural and functional characteristics of oestrogen receptor β splice variants: Implications for the ageing brain.

C K Kim1, A Torcaso1, A Asimes1, W C J Chung2, T R Pak1.   

Abstract

Oestrogen receptor (ER)β is a multifunctional nuclear receptor that mediates the actions of oestrogenic compounds. Despite its well defined role in mediating the actions of oestrogens, a substantial body of evidence demonstrates that ERβ has a broad range of physiological functions independent of those normally attributed to oestrogen signalling. These functions can partly be achieved by the activity of several alternatively spliced isoforms that have been identified for ERβ. This short review describes structural differences between the ERβ splice variants that are known to be translated into proteins. Moreover, we discuss how these alternative structures contribute to functional differences in the context of both healthy and pathological conditions. Our review also describes the principal factors that regulate alternative RNA splicing. The alternatively spliced isoforms of ERβ are differentially expressed according to brain region, age and hormonal milieu, emphasising the likelihood that there are precise cell-specific mechanisms regulating ERβ alternative splicing. However, despite these correlative data, the molecular factors regulating alternative ERβ splicing in the brain remain unknown. We also review the basic mechanisms that regulate alternative RNA splicing and use that framework to make logical predictions about ERβ alternative splicing in the brain.
© 2017 British Society for Neuroendocrinology.

Entities:  

Keywords:  alternative splicing; brain; oestrogen receptor β; splice variants

Mesh:

Substances:

Year:  2018        PMID: 28514502      PMCID: PMC5693782          DOI: 10.1111/jne.12488

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  79 in total

1.  A brain-derived MeCP2 complex supports a role for MeCP2 in RNA processing.

Authors:  Steven W Long; Jenny Y Y Ooi; Peter M Yau; Peter L Jones
Journal:  Biosci Rep       Date:  2011-10       Impact factor: 3.840

2.  Identification of a splice variant of the rat estrogen receptor beta gene.

Authors:  S Chu; P J Fuller
Journal:  Mol Cell Endocrinol       Date:  1997-09-19       Impact factor: 4.102

Review 3.  Modulation of nuclear receptor activity by the F domain.

Authors:  Shivali R Patel; Debra F Skafar
Journal:  Mol Cell Endocrinol       Date:  2015-07-13       Impact factor: 4.102

4.  Estrogen receptor β transcript variants associate with oncogene expression in endometrial cancer.

Authors:  Julia Häring; Maciej Skrzypczak; Anette Stegerer; Claus Lattrich; Florian Weber; Regina Görse; Olaf Ortmann; Oliver Treeck
Journal:  Int J Mol Med       Date:  2012-02-28       Impact factor: 4.101

5.  Estrogen receptor beta splice variant mRNAs are differentially altered during breast carcinogenesis.

Authors:  Indra Poola; Jessy Abraham; Aiyi Liu
Journal:  J Steroid Biochem Mol Biol       Date:  2002-10       Impact factor: 4.292

6.  A novel isoform of rat estrogen receptor beta with 18 amino acid insertion in the ligand binding domain as a putative dominant negative regular of estrogen action.

Authors:  K Maruyama; H Endoh; H Sasaki-Iwaoka; H Kanou; E Shimaya; S Hashimoto; S Kato; H Kawashima
Journal:  Biochem Biophys Res Commun       Date:  1998-05-08       Impact factor: 3.575

7.  Correlation of mRNA for oestrogen receptor beta splice variants ERbeta1, ERbeta2/ERbetacx and ERbeta5 with outcome in endocrine-treated breast cancer.

Authors:  M P A Davies; P A O'Neill; H Innes; D R Sibson; W Prime; C Holcombe; C S Foster
Journal:  J Mol Endocrinol       Date:  2004-12       Impact factor: 5.098

8.  Decreased alternative splicing of estrogen receptor-α mRNA in the Alzheimer's disease brain.

Authors:  Tatjana A Ishunina; Dick F Swaab
Journal:  Neurobiol Aging       Date:  2010-04-24       Impact factor: 4.673

9.  The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions.

Authors:  P Webb; P Nguyen; C Valentine; G N Lopez; G R Kwok; E McInerney; B S Katzenellenbogen; E Enmark; J A Gustafsson; S Nilsson; P J Kushner
Journal:  Mol Endocrinol       Date:  1999-10

10.  Estrogen receptor domains E and F: role in dimerization and interaction with coactivator RIP-140.

Authors:  G A Peters; S A Khan
Journal:  Mol Endocrinol       Date:  1999-02
View more
  7 in total

Review 1.  Interactions between estradiol, diabetes, and brain aging and the risk for cognitive impairment.

Authors:  C E Hugenschmidt; T Duran; M A Espeland
Journal:  Climacteric       Date:  2021-02-15       Impact factor: 3.024

Review 2.  Nuclear Receptors in Myocardial and Cerebral Ischemia-Mechanisms of Action and Therapeutic Strategies.

Authors:  Joanna Rzemieniec; Laura Castiglioni; Paolo Gelosa; Majeda Muluhie; Benedetta Mercuriali; Luigi Sironi
Journal:  Int J Mol Sci       Date:  2021-11-15       Impact factor: 5.923

Review 3.  Estrogen receptors and the aging brain.

Authors:  Silvia Maioli; Karin Leander; Per Nilsson; Ivan Nalvarte
Journal:  Essays Biochem       Date:  2021-12-17       Impact factor: 8.000

Review 4.  Estrogen and Estrogen Receptor Modulators: Potential Therapeutic Strategies for COVID-19 and Breast Cancer.

Authors:  Shuying Hu; Feiying Yin; Litao Nie; Yuqin Wang; Jian Qin; Jian Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-23       Impact factor: 5.555

Review 5.  The race to develop oral SERDs and other novel estrogen receptor inhibitors: recent clinical trial results and impact on treatment options.

Authors:  Yating Wang; Shou-Ching Tang
Journal:  Cancer Metastasis Rev       Date:  2022-10-14       Impact factor: 9.237

Review 6.  Estrogen Interactions With Lipid Rafts Related to Neuroprotection. Impact of Brain Ageing and Menopause.

Authors:  Raquel Marin; Mario Diaz
Journal:  Front Neurosci       Date:  2018-03-06       Impact factor: 4.677

Review 7.  Gender Predilection in Sporadic Parathyroid Adenomas.

Authors:  Maria P Yavropoulou; Athanasios D Anastasilakis; Argyro Panagiotakou; Evanthia Kassi; Polyzois Makras
Journal:  Int J Mol Sci       Date:  2020-04-22       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.